51 research outputs found

    Response to Treatment and Disease Progression Linked to CD4+ T Cell Surface CC Chemokine Receptor 5 Density in Human Immunodeficiency Virus Type 1 Vertical Infection

    Get PDF
    The factors governing interindividual variability in disease progression among children vertically infected with human immunodeficiency virus type 1 (HIV-1) remain unclear. Because it has recently been shown in infected adults that the density of CC chemokine receptor 5 (CCR5) molecules at the surface of nonactivated (human leukocyte antigen [HLA]-DR-) CD4+ T cells correlates with disease progression, the same correlation was sought in children. HLA-DR-CD4+ T cell surface CCR5 density was constant over time and correlated with the bioclinical stage and with the CD4 cell slope observed before antiretroviral treatment. In addition, CCR5 density was negatively correlated with the intensity of the decrease in viremia during antiretroviral therapy and was positively correlated with CD4 cell slope since birth. These results are compatible with the hypothesis that CCR5 density is a key factor governing disease progression in pediatric HIV-1 infection and, thereby, an indicator of prognosis. Moreover, they suggest that therapies aimed at reducing CCR5 accessibility should slow down HIV disease evolution in childre

    L'hormone anti-müllerienne

    No full text
    PARIS-BIUP (751062107) / SudocSudocFranceF

    La larvothérapie dans le traitement du pied diabétique

    No full text
    PARIS-BIUP (751062107) / SudocSudocFranceF

    La maladie de Hashimoto

    No full text
    PARIS-BIUP (751062107) / SudocSudocFranceF

    Diabète insipide et grossesse

    No full text
    PARIS-BIUP (751062107) / SudocSudocFranceF

    De l'érythropoïetine endogène à l'érythropoïetine humaine recombinante

    No full text
    PARIS-BIUP (751062107) / SudocSudocFranceF

    Probiotiques et maladies inflammatoires chroniques de l'intestin

    No full text
    PARIS-BIUP (751062107) / SudocSudocFranceF

    Aspect pratique des traitements de la dysthyroïdie

    No full text
    PARIS-BIUP (751062107) / SudocSudocFranceF
    corecore